Dr. Antonio Ricardo Cheesman Rocca, MD

Dr. Cheesman Rocca practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Cheesman Rocca's NPI, 1689014276, was assigned on June 27, 2013. Dr. Cheesman Rocca holds Missouri license 2020010662.

Dr. Cheesman Rocca's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Cheesman Rocca's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. Dr. Cheesman Rocca is also affiliated with SSM Health St. Mary's Hospital - St. Louis. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Cheesman Rocca to 1 more behavioral health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheesman Rocca practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Cheesman Rocca's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Cheesman Rocca is licensed in Missouri.

CMS data shows 374 Medicare services from Dr. Cheesman Rocca across 14 procedure codes in 2024, for 249 Medicare patients. Medicare paid $30,577 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Cheesman Rocca in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheesman Rocca's median patient age at 63, with 53% women.

In 2024, Dr. Cheesman Rocca wrote 447 Medicare Part D claims for 198 patients. 76% of them were for generic drugs. CMS names the drug for 346 of them, across 12 drugs with 11 or more claims each, at $156,761 in total drug cost. In 2023, CMS named 422 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Cheesman Rocca for performance year 2024, reported as part of a group. Dr. Cheesman Rocca accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 181 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Cheesman Rocca, more than 88% of the clinicians it reports for that procedure.

CMS Open Payments shows 18 general payments to Dr. Cheesman Rocca from 7 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 59% of the total. Olympus Corporation of the Americas paid the most, $814.